Development of peptide and protein based radiopharmaceuticals.
about
Evaluation of the Efficacy of Targeted Imaging AgentsNovel small peptides derived from VEGF125-136: potential drugs for radioactive diagnosis and therapy in A549 tumor-bearing nude mice.Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier.Development of a novel, fibrin-specific PET tracer.MRI Contrast Agents for Pharmacological Research.Development of 6-[(18) F]fluoro-carbohydrate-based prosthetic groups and their conjugation to peptides via click chemistry.Analysis of iodinated quorum sensing peptides by LC-UV/ESI ion trap mass spectrometry.
P2860
Q28074924-44E51103-88E2-420A-9042-809D04078F38Q33842838-51A6ED56-30A7-4436-8BF7-5A5D7EE36ACBQ34500499-653EF73B-80BF-4273-8EDF-BF1CCC7B6113Q38895099-D39B7087-3DCE-4B28-B8C9-0535CCBB299AQ42084719-6620963C-0CC4-4F87-B315-7C0884B5CC78Q52986133-D41B663C-D8E7-4225-B83B-4A43E6E1AE11Q55285591-742ED13F-298B-42D0-A3B0-AF72F17B7AF6
P2860
Development of peptide and protein based radiopharmaceuticals.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Development of peptide and protein based radiopharmaceuticals.
@en
type
label
Development of peptide and protein based radiopharmaceuticals.
@en
prefLabel
Development of peptide and protein based radiopharmaceuticals.
@en
P2093
P1476
Development of peptide and protein based radiopharmaceuticals
@en
P2093
Evelien Wynendaele
Nathalie Bracke
Sofie Stalmans
P304
P356
10.2174/13816128113196660663
P577
2014-01-01T00:00:00Z